Angiotensin II receptor blockade and skeletal muscle metabolism in overweight and obese adults with elevated blood pressure.

@article{Boutagy2015AngiotensinIR,
  title={Angiotensin II receptor blockade and skeletal muscle metabolism in overweight and obese adults with elevated blood pressure.},
  author={Nabil Boutagy and Elaina L. Marinik and Ryan McMillan and Angela Suzanne Anderson and Madlyn Irene Frisard and Brenda M Davy and Jos{\'e} Miguel Rivero and Kevin P. Davy and Matthew W Hulver},
  journal={Therapeutic advances in cardiovascular disease},
  year={2015},
  volume={9 2},
  pages={
          45-50
        }
}
OBJECTIVES Whether angiotensin II receptor blockade improves skeletal muscle fatty acid oxidation in overweight and obese humans is unknown. The purpose of the study was to test the hypothesis that the angiotensin II receptor blocker, olmesartan, would increase fatty acid oxidation and the activity of enzymes associated with oxidative metabolism in skeletal muscle of overweight and obese humans. METHODS A total of 12 individuals (6 men and 6 women) aged 18-75 and with a body mass index ⩾25 kg… CONTINUE READING
Tweets
This paper has been referenced on Twitter 4 times. VIEW TWEETS

References

Publications referenced by this paper.
SHOWING 1-10 OF 27 REFERENCES

The effects of longterm valsartan treatment on skeletal muscle fatty acid handling in humans with impaired glucose metabolism

  • C. Moors, E. Blaak, N. Van Der Zijl, M. Diamant, G. Goossens
  • J Clin Endocrinol Metab
  • 2013
2 Excerpts

Similar Papers

Loading similar papers…